BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 31933935)

  • 1. Triptolide reduces proliferation and enhances apoptosis in drug-resistant human oral cancer cells.
    Tian L; Zhang Y; Wang Y; Dang R; Fu Z; Gu B; Wen N
    Int J Clin Exp Pathol; 2019; 12(4):1204-1213. PubMed ID: 31933935
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Triptolide exerts pro-apoptotic and cell cycle arrest activity on drug-resistant human lung cancer A549/Taxol cells via modulation of MAPK and PI3K/Akt signaling pathways.
    Xie CQ; Zhou P; Zuo J; Li X; Chen Y; Chen JW
    Oncol Lett; 2016 Nov; 12(5):3586-3590. PubMed ID: 27900040
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Triptolide inhibits the multidrug resistance in prostate cancer cells via the downregulation of MDR1 expression.
    Guo Q; Nan XX; Yang JR; Yi L; Liang BL; Wei YB; Zhu N; Hu SB; Zhang H; Luo Y; Xu YF
    Neoplasma; 2013; 60(6):598-604. PubMed ID: 23906293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Triptolide reverses the Taxol resistance of lung adenocarcinoma by inhibiting the NF-κB signaling pathway and the expression of NF-κB-regulated drug-resistant genes.
    Jiang N; Dong XP; Zhang SL; You QY; Jiang XT; Zhao XG
    Mol Med Rep; 2016 Jan; 13(1):153-9. PubMed ID: 26531258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological and small interference RNA-mediated inhibition of breast cancer-associated fatty acid synthase (oncogenic antigen-519) synergistically enhances Taxol (paclitaxel)-induced cytotoxicity.
    Menendez JA; Vellon L; Colomer R; Lupu R
    Int J Cancer; 2005 May; 115(1):19-35. PubMed ID: 15657900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Triptolide induces S phase arrest via the inhibition of cyclin E and CDC25A and triggers apoptosis via caspase- and mitochondrial-dependent signaling pathways in A375.S2 human melanoma cells.
    Hung FM; Chen YL; Huang AC; Hsiao YP; Yang JS; Chung MT; Chueh FS; Lu HF; Chung JG
    Oncol Rep; 2013 Mar; 29(3):1053-60. PubMed ID: 23314229
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Triptolide exerts anti-tumor effect on oral cancer and KB cells in vitro and in vivo.
    Chen YW; Lin GJ; Chia WT; Lin CK; Chuang YP; Sytwu HK
    Oral Oncol; 2009 Jul; 45(7):562-8. PubMed ID: 19359213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Triptolide represses oral cancer cell proliferation, invasion, migration, and angiogenesis in co-inoculation with U937 cells.
    Yang CY; Lin CK; Lin GJ; Hsieh CC; Huang SH; Ma KH; Shieh YS; Sytwu HK; Chen YW
    Clin Oral Investig; 2017 Jan; 21(1):419-427. PubMed ID: 27073100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 3-acetyl-11-keto-beta-boswellic acid decreases the malignancy of taxol resistant human ovarian cancer by inhibiting multidrug resistance (MDR) proteins function.
    Jin L; Yingchun W; Zhujun S; Yinan W; Dongchen W; Hui Y; Xi Y; Wanzhou Z; Buluan Z; Jinhua W
    Biomed Pharmacother; 2019 Aug; 116():108992. PubMed ID: 31129513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Triptolide-Mediated Apoptosis by Suppression of Focal Adhesion Kinase through Extrinsic and Intrinsic Pathways in Human Melanoma Cells.
    Kwon HY; Kim KS; Baik JS; Moon HI; Lee JW; Kim CH; Cho YS; Jeong YK; Lee YC
    Evid Based Complement Alternat Med; 2013; 2013():172548. PubMed ID: 25945102
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Raman spectrum reveals the cell cycle arrest of Triptolide-induced leukemic T-lymphocytes apoptosis.
    Zhang D; Feng Y; Zhang Q; Su X; Lu X; Liu S; Zhong L
    Spectrochim Acta A Mol Biomol Spectrosc; 2015 Apr; 141():216-22. PubMed ID: 25681805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Triptolide synergistically enhances temozolomide-induced apoptosis and potentiates inhibition of NF-κB signaling in glioma initiating cells.
    Sai K; Li WY; Chen YS; Wang J; Guan S; Yang QY; Guo CC; Mou YG; Li WP; Chen ZP
    Am J Chin Med; 2014; 42(2):485-503. PubMed ID: 24707876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined Treatment with Triptolide and Tyrosine Kinase Inhibitors Synergistically Enhances Apoptosis in Non-small Cell Lung Cancer H1975 Cells but Not H1299 Cells through EGFR/Akt Pathway.
    Tong X; Jiang P; Li Y; Guo L; Zhang HM; Zhang BK; Yan M
    Chem Pharm Bull (Tokyo); 2019 Aug; 67(8):864-871. PubMed ID: 31142691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Triptolide induces apoptosis and inhibits the growth and angiogenesis of human pancreatic cancer cells by downregulating COX-2 and VEGF.
    Ma JX; Sun YL; Wang YQ; Wu HY; Jin J; Yu XF
    Oncol Res; 2013; 20(8):359-68. PubMed ID: 23924856
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Triptolide avoids cisplatin resistance and induces apoptosis via the reactive oxygen species/nuclear factor-κB pathway in SKOV3
    Zhong YY; Chen HP; Tan BZ; Yu HH; Huang XS
    Oncol Lett; 2013 Oct; 6(4):1084-1092. PubMed ID: 24137468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-tumor effects of triptolide on angiogenesis and cell apoptosis in osteosarcoma cells by inducing autophagy via repressing Wnt/β-Catenin signaling.
    Li X; Lu Q; Xie W; Wang Y; Wang G
    Biochem Biophys Res Commun; 2018 Feb; 496(2):443-449. PubMed ID: 29330051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel target genes responsive to the anti-growth activity of triptolide in endometrial and ovarian cancer cells.
    Li H; Takai N; Yuge A; Furukawa Y; Tsuno A; Tsukamoto Y; Kong S; Moriyama M; Narahara H
    Cancer Lett; 2010 Nov; 297(2):198-206. PubMed ID: 20547442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergistic antitumour effects of triptolide plus 10-hydroxycamptothecin onbladder cancer.
    Wang T; Ding Y; Yang Y; Wang Z; Gao W; Li D; Wei J; Sun Y
    Biomed Pharmacother; 2019 Jul; 115():108899. PubMed ID: 31063955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Triptolide inhibits cell growth and GRP78 protein expression but induces cell apoptosis in original and radioresistant NPC cells.
    Li C; Zhang B; Lv W; Lai C; Chen Z; Wang R; Long X; Feng X
    Oncotarget; 2016 Aug; 7(31):49588-49596. PubMed ID: 27391061
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targets and molecular mechanisms of triptolide in cancer therapy.
    Meng C; Zhu H; Song H; Wang Z; Huang G; Li D; Ma Z; Ma J; Qin Q; Sun X; Ma J
    Chin J Cancer Res; 2014 Oct; 26(5):622-6. PubMed ID: 25400429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.